Oncogenic B-RafV600E Abrogates the AKT/B-Raf/Mps1 Interaction in Melanoma Cells

Ling Zhang,Ruyi Shi,Chanting He,Caixia Cheng,Bin Song,Heyang Cui,Yanyan Zhang,Zhiping Zhao,Yanghui Bi,Xiaofeng Yang,Xiaoping Miao,Jiansheng Guo,Xing Chen,Jinfen Wang,Yaoping Li,Xiaolong Cheng,Jing Liu,Yongping Cui

DOI: https://doi.org/10.1016/j.canlet.2013.05.029

IF: 9.756

2013-01-01

Cancer Letters

Abstract:Activating B-Raf mutations that deregulate the mitogen-activated protein kinase (MAPK) pathway commonly occur in cancer. Although B-Raf(V600E) induces increased Mps1 protein contributing to centrosome amplification and chromosome instability, the regulatory mechanisms of Mps1 in melanoma cells is not fully understood. Here, we report that Mps1/AKT and B-Raf(WT)/ERK signaling form an auto-regulatory negative feedback loop in melanoma cells; notably, oncogenic B-Raf(V600E) abrogates the negative feedback loop, contributing the aberrant Mps1 functions and tumorigenesis. Our findings raise the possibility that targeting the oncogenic B-Raf and Mps1, especially when used in combination could potentially provide great therapeutic opportunities for cancer treatment.